证券日报网讯1月29日，广誉远（600771）在互动平台回答投资者提问时表示，独家产品加味龟龄集药 酒，公司已在线上线下（300959）布局售卖且不断优化渠道，根据相关法规该药酒不可进行广告宣传， 但公司结合自身情况，持续对公司品牌、远字牌龟龄集保健酒、定坤丹(OTC)等通过高铁冠名、平台传 播、官媒推广等多种途径持续曝光，不断增加知名度和影响力，持续扩大品牌声量。 ...

证券日报网讯1月29日，广誉远（600771）在互动平台回答投资者提问时表示，公司已于2026年1月17日 披露《关于董事会延期换届及部分独立董事任期届满的提示性公告》，目前公司董事会换届选举工作尚 在筹备中，不存在提名的独立董事人选未通过资格审查的情形。公司将积极推进相关工作，并及时履行 信息披露义务。 ...

证券之星消息，1月29日中药板块较上一交易日上涨0.98%，片仔癀领涨。当日上证指数报收于4157.98， 上涨0.16%。深证成指报收于14300.08，下跌0.3%。中药板块个股涨跌见下表： 从资金流向上来看，当日中药板块主力资金净流入1210.05万元，游资资金净流出9243.6万元，散户资金 净流入8033.56万元。中药板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 600436 | 片仔瘦 | 2.4216 | 11.07% | -9063.85万 | -4.15% | -1.51 Z | -6.92% | | 600085 | 同仁堂 | 5722.98万 | 9.44% | -1391.28万 | -2.30% | -4331.71万 | -7.15% | | 600771 | 广营远 | 4647.58万 | 12.43% | -2690.82万 | -7.20% | - ...

（来源：北京证监局） 来源：北京证监局 蒋淑霞、王兴杰、乔鑫： 登录新浪财经APP 搜索【信披】查看更多考评等级 经查，你们在广誉远（维权）中药股份有限公司（以下简称广誉远）2016年至2018年年度财务报表审计 项目（审计报告文号：利安达审字〔2017〕第2077号、利安达审字〔2018〕第2161号、利安达审字 〔2019〕第2088号）执业中存在以下问题： 2.访谈程序执行不到位。2016年、2017年年报审计，未考虑访谈回复中有关退换货及付款条款对营业收 入确认的影响；2018年年报审计，对访谈回复显示的销售数量及金额与当年实际严重不符的异常情况未 予关注，未进一步查验并判断广誉远营业收入处理是否符合相关规定。 3.合同检查程序执行不到位。2016年至2018年年报审计，未关注合同中有关非质量问题可退换货或根据 实际销售情况付款的条款对营业收入确认的影响；2017年、2018年年报审计，未关注合同中明确约定需 要购货方提供的货物流向表，未进一步了解下游商业公司实际库存及销售广誉远商品的情况，进而未发 现商业公司库存充足、历史销量小，但广誉远仍向其压货的明显异常；2017年年报审计，执行合同检查 流于形 ...

（编辑 任世碧） 证券日报网讯 1月22日，广誉远在互动平台回答投资者提问时表示，公司董事会换届相关工作已按照监 管规则于2026年1月17日发布了提示公告，已表明："公司董事会换届选举工作完成前，赵选民将继续履 行其独立董事及各专门委员会职责，第八届董事会全体成员及高级管理人员任期相应顺延，不会影响公 司的正常运营。"如有新进展，请关注公司公告。 ...

Group 1 - The core issue involves investor claims against Guangyuyuan (600771) for false statements, with ongoing legal proceedings initiated by attorney Xu Feng [1] - The company was found to have misrepresented its "buyout sales" model in annual reports from 2016 to 2021, leading to premature revenue recognition and incorrect handling of sales expenses [1] - The administrative penalty from the China Securities Regulatory Commission (CSRC) was issued on April 11, 2024, confirming the violations [1] Group 2 - Investors who purchased Guangyuyuan stock between March 21, 2017, and December 29, 2023, are eligible to file claims [2] - Attorney Xu Feng is also handling claims for Tianwo Technology (002564), which has seen successful settlements for some investors [2] - Tianwo Technology was found to have false records in its periodic reports and failed to disclose related party transactions and the use of raised funds [3][4]

Group 1 - The company's eighth board of directors will expire on January 17, 2026, and the board's election work is still in preparation, leading to a postponement of the board's renewal [2] - To ensure continuity and stability, the terms of the board's special committees and senior management will be extended accordingly until the board's election is completed [2] - The current independent director, Zhao Xuanmin, has served since January 15, 2020, and will reach the six-year limit for continuous service, but will continue to fulfill his duties until new independent directors are elected [3] Group 2 - The postponement of the board's renewal will not affect the company's normal operations, and the company will actively promote related work and fulfill its information disclosure obligations in a timely manner [4]

Core Viewpoint - Guangyuyuan (600771) emphasizes its commitment to investor communication and the continuous improvement of its operational quality, aiming for double-digit growth in key performance indicators by 2025 [1] Group 1: Investor Communication - The company actively monitors various investor communication platforms and values objective feedback from investors, which is analyzed and reported to management [1] - Historical performance is acknowledged, but the company focuses on current and future operations without complacency [1] Group 2: Operational Performance - The company projects double-digit growth in its three periodic reports for 2025, with significant improvements in cash flow, accounts receivable, and sales expense ratio [1] - Evidence of operational success includes enhanced brand collaboration, top-tier chain partnerships, and the first national approval for Banxia Xiexin Decoction granules [1] Group 3: Future Strategy - For 2026, the company will prioritize "growth" as a value anchor and adopt a proactive mindset to achieve results, ensuring sustainable and high-quality development [1]

Group 1 - The company Guangyuyuan announced that its eighth board of directors will expire on January 17, 2026, and the board's election work is currently in preparation [2] - The board's term extension aims to ensure continuity and stability in the company's operations, with all specialized committees and senior management's terms being extended accordingly [2] - The current independent director, Zhao Xuanmin, has served since January 15, 2020, and will reach the six-year limit for continuous service before the board's election is completed [2]

Core Viewpoint - The company is actively monitoring sales dynamics of similar products in the industry and analyzing successful brands' marketing strategies to enhance its own competitiveness [1] Group 1: Company Strategy - The company has a diverse range of alcoholic products with historical brand value and notable quality advantages [1] - The company acknowledges its current disadvantages in product channel coverage, brand market competitiveness, and purchasing scenarios [1] - A new operational plan has been developed to launch different specifications like "Youth Small Cannon and Family Gift Box" to cater to various consumer needs and usage scenarios [1] Group 2: Marketing and Expansion Efforts - The company is focusing on regional pilot projects based in Shanxi to expand nationwide through various channels [1] - Marketing efforts include online and offline strategies such as exposure on China Railway 12306, public accounts, video accounts, and offline pop-up events [1] - The alcoholic beverage business currently represents a small proportion of the company's overall revenue, and investors are advised to view this with rationality [1]